Authors
Loading...
Metabolomic and transcriptomic analysis reveals impaired brain cholesterol synthesis and catabolism in Alzheimer's disease, suggesting potential targets for therapeutic intervention.
Varma et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: